(S)-(-)-7’-[4(S)-(Benzyl)oxazol-2-yl]-7-di(3,5-di-t-butylphenyl)phosphino-2,2’,3,3’-tetrahydro-1,1’-spirobiindane, min. 97%  (Sa,S)-DTB-Bn-SIPHOX,(S) - ( - )-7'-〔4(S) - (苄基)恶唑-2 - 基]-7-二(3,5  - 二 - 叔丁基苯基)膦基-2,2',3,3'-四氢-1,1?螺二氢茚 , min. 97%
(S)-(-)-7’-[4(S)-(Benzyl)oxazol-2-yl]-7-di(3,5-di-t-butylphenyl)phosphino-2,2’,3,3’-tetrahydro-1,1’-spirobiindane, min. 97% (Sa,S)-DTB-Bn-SIPHOX
(S) - ( - )-7'-〔4(S) - (苄基)恶唑-2 - 基]-7-二(3,5 - 二 - 叔丁基苯基)膦基-2,2',3,3'-四氢-1,1?螺二氢茚 , min. 97%
产品编号
15-5191
CAS
纯度
min. 97%
分子式
C55H66NOP
分子量
788.09
品牌
Strem
收藏
25mg
期货: 3~5 Weeks
   ¥ 1680
100mg
期货: 3~5 Weeks
   ¥ 5040

Technical Notes

1. Chiral ligands for the iridium-catalyzed, asymmetric hydrogenation of imines.

2.Chiral ligands for the iridium-catalyzed, asymmetric hydrogenation of a-ß unsaturated carboxylic acids.

3. Chiral ligands for iridium-catalyzed, asymmetric hydrogenation of a,-oxy-a,ß-

unsaturated carboxylic acids.

References:

1.J. Am. Chem. Soc., 2006, 128, 12886.

2J. Am. Chem. Soc., 2008, 130, 8584.

3.J. Am. Chem. Soc., 2010, 132, 1172.

产品分类